| abstract |
The invention relates to therapeutically active azaheterocyclic compounds, a process for their preparation and the pharmaceutical compositions containing them. The compounds are useful in the treatment of diseases of the central nervous system associated with gavage inversion. They are of the formula wherein a is a saturated or unsaturated five-membered six-membered carbon ring optionally substituted with phenyl, benzylidene, C 1-4 -alkyl substituted with phenyl or C 2-4 -alkenyl substituted with phenyl, said phenyllyl benzylidene being optionally substituted with halogen, C1-4-alkyl, C1-4-alkoxy or trifluoromethyl, wherein the saturated or unsaturated five-membered six-carbon carbon ring is optionally bonded to the benzene ring. |